trial · primary record
AFSW Guided DOAC
Atrial Fibrillation
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 5350 |
| Primary completion | 2029-07-31 |
| Primary endpoint | To assess whether AFSW-guided, time-delimited DOAC therapy is non-inferior to continuous DOAC therapy for a composite endpoint that includes: (1) Ischemic stroke; (2) Systemic embolism; (3) All-cause mortality. |
| Registry ID | NCT05836987 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:03.114Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05836987
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.